PARP Inhibitors for the Treatment of Ovarian Cancer: Rationale and Clinical Outcomes – Presentation by Dr. Karen McLean at the MCGA Annual Meeting, April 2016.
PARP Inhibitors for the Treatment of Ovarian Cancer: Rationale and Clinical Outcomes – Presentation by Dr. Karen McLean at the MCGA Annual Meeting, April 2016.